Full-Time

Key Accounts Manager

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Mid, Senior

Odisha, India

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Requirements
  • University Science graduate.
  • 3+ years of sales experience required.
  • Thorough Product Knowledge
  • Aptitude for establishing and nurturing strategic relationships.
  • Comprehensive understanding of the Pharmaceutical Industry.
  • Effective Influencing and Communication Skills.
  • Proficiency in Customer Management.
  • Strong Commercial Acumen.
  • Proven Selling Skills.
  • Organizational skills, good analytical skills / mind set, ability to manage complexity with a high degree of maturity.
  • Must have completed 1+ years in AZ.
  • Proficient in oral and written communication (English).
Responsibilities
  • Develop account strategy and plans
  • Identify opportunities and strategies to improve positioning of AZ's Oncology products at a local level.
  • Work with Sales Manager to develop a local strategy and business plan to meet targets and further improve positioning of AZ's Oncology products at a local level.
  • Engage Oncology HCPs in dialogue about approved indications, product efficacy / safety profiles and treatment protocols to support on-label prescribing for appropriate patients.
  • Establish and maintain ongoing, long term collaborative relationships with stakeholders.
  • Share stakeholder insight and information within AZ to strengthen relevant activities, e.g., product development, marketing, sales efforts.
  • Build knowledge and understanding about AZ's overall Oncology value proposition, and product's labelled indications and efficacy data among all relevant stakeholders in the MDT and DMU.
  • Utilise different communication approaches, techniques and channels to help build knowledge in the MDT and DMU, including conducting science-based discussions with the HCP as per the approved indications of AZ's products.
  • Arrange multidisciplinary workshops for physicians and other healthcare professionals.
  • Arrange and coordinate effective speaker programmes with physician advocates and KOLs.
  • Drive sales performance and ensure sales forecasts meet or exceed expectations while managing assigned budgets.
  • Successfully promote the benefits of AZ's Oncology brands, using fair balance messages and the appropriate mix of promotional tools.
  • Ensure AZ's products are optimally utilised in line with national/local guidelines and the product license.
  • Successfully complete all training requirements, including product examinations.
  • Comply with all external regulations and internal policies.
  • Ensure compliance with the AZ Code of Ethics, Global External Interactions Policy and Standards, and Privacy Policy and Standards, especially when interacting with Patient Groups.
Desired Qualifications
  • Experience in super- speciality / Oncology preferred.
  • Able to identify potential customers and add to the customer base.
  • Able to meet demand generation goals.
  • Should have been a high performer in sales.
  • Cross functional engagement, strong business acumen.

AstraZeneca focuses on discovering, developing, and selling prescription medicines, primarily in three areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Their products are developed through extensive research and development, which includes rigorous clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery accelerates AstraZeneca's development of new therapies.
  • Real-world evidence enhances clinical trials, leading to faster regulatory approvals for AstraZeneca.
  • Personalized medicine advancements enable AstraZeneca to offer targeted and effective treatments.

What critics are saying

  • AI pre-screening tools may face ethical and accuracy challenges, impacting AstraZeneca's collaborations.
  • Foreign investment in France could be at risk due to regulatory changes or instability.
  • Post-market surveillance challenges may arise for Imfinzi's approvals in the EU and US.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing resources with the scientific community.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

Europawire
Apr 8th, 2025
AstraZeneca Unveils Breakthrough Data on Vaccines and Antibody Therapies for Infections

AstraZeneca unveils breakthrough data on vaccines and antibody therapies for infections.

Delcade
Apr 4th, 2025
Foreign investment in France: Key trends, legal considerations (2024)

AstraZeneca invested €365 million in expanding its production lines in Dunkirk.